Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid vs ClinOleic in ICU Patients Requiring Parenteral Nutrition
NCT00600912Phase 4Completed
- Sponsor
- Klinikum Ludwigshafen
- Start
- Dec 2006
- Primary completion
- Dec 2007
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised trial of SMOFlipid (2 arms), sponsored by Klinikum Ludwigshafen. Primary endpoint: Leucotriene B5 at 5 days. Started Dec 2006; status: completed.
02
Drugs
SMOFlipid
Beyond the preview
Go deeper on NCT00600912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600912.